Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for D Valeant Pharmaceuticals Intl (4107485Q)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2010 Q4 | 0 | 0.00 | Sell 100.00% | 0.40 | SEC | ||
| 2010 Q3 | 1,820,432 | 0.40 | Add 50.04% | 0.13 | $25.05 | $45,602,000 | SEC |
| 2010 Q2 | 1,213,280 | 0.65 | Buy | 0.65 | $52.29 | $63,442,000 | SEC |
| 2010 Q1 | 0 | 0.00 | Sell 100.00% | 0.57 | SEC | ||
| 2009 Q4 | 1,402,570 | 0.57 | Reduce 17.81% | 0.11 | $31.79 | $44,588,000 | SEC |
| 2009 Q3 | 1,706,450 | 0.61 | Add 11.27% | 0.06 | $28.06 | $47,883,000 | SEC |
| 2009 Q2 | 1,533,650 | 0.63 | Add 1.39% | <0.01 | $25.72 | $39,445,000 | SEC |
| 2009 Q1 | 1,512,650 | 0.51 | Add 15.34% | 0.07 | $17.79 | $26,910,000 | SEC |
| 2008 Q4 | 1,311,450 | 0.57 | Add 5.60% | 0.03 | $22.90 | $30,032,000 | SEC |
| 2008 Q3 | 1,241,950 | 0.37 | Add 44.39% | 0.11 | $20.47 | $25,423,000 | SEC |
| 2008 Q2 | 860,130 | 0.18 | Add 69.43% | 0.07 | $17.11 | $14,717,000 | SEC |
| 2008 Q1 | 507,660 | 0.08 | Add 699.80% | 0.07 | $12.83 | $6,513,000 | SEC |
| 2007 Q4 | 63,473 | 0.01 | Add 353.38% | <0.01 | $11.97 | $760,000 | SEC |
| 2007 Q3 | 14,000 | <0.01 | Buy | <0.01 | $15.50 | $217,000 | SEC |
| 2007 Q2 | 0 | 0.00 | Sell 100.00% | 0.13 | SEC | ||
| 2007 Q1 | 692,200 | 0.13 | Reduce 17.61% | 0.03 | $17.29 | $11,968,000 | SEC |
| 2006 Q4 | 840,178 | 0.17 | Reduce 16.42% | 0.04 | $17.24 | $14,485,000 | SEC |
| 2006 Q3 | 1,005,200 | 0.27 | Reduce 1.37% | <0.01 | $19.78 | $19,883,000 | SEC |
| 2006 Q2 | 1,019,200 | 0.24 | $16.92 | $17,245,000 | SEC |